EpicentRx Inc

About:

EpicentRx Inc is a clinical-stage immuno-oncology company.

Website: http://www.epicentrx.com/

Top Investors: Michael J. Fox Foundation

Description:

With a prolific platform of small molecule therapies, innate immune checkpoint inhibitors, cell based therapies, vaccines and oncolytic viruses, the central focus of EpicentRx Inc., a privately owned physician-led phase 3 clinical-stage immuno-oncology company located in San Diego, California, is on anticancer immunization and chemo/radioprotection of normal tissues. As a company of actively practicing oncologists/internists they at EpicentRx take cancer very very personally (in a literal and figurative sense) with the plight of the patient serving first and foremost as the motivation to customize or personalize their platform of immunotherapies both to individuals that are otherwise out of options and to groups of individuals with common and in many cases currently undruggable mutations.

Total Funding Amount:

$35.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

La Jolla, California, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)epicentrx.com

Founders:

Jan Scicinski

Number of Employees:

11-50

Last Funding Date:

2022-07-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai